SA141H01UKH9
SA141H01UKH9
Middle East Healthcare Co.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.55B EUR | 2.93B EUR | 3.19B EUR | 3B EUR |
Enterprise Value | 5B EUR | 5.33B EUR | 5.63B EUR | 5.51B EUR |
Valuation Multiples | ||||
Trailing P/E | 17.4x | 21.23x | 25.82x | 30.61x |
Forward P/E | 7.4x | -- | -- | -- |
Price to Sales | 0.8x | 0.92x | 1.02x | 1.27x |
Price to Book | 1.65x | 1.9x | 1.68x | 1.6x |
EV/Revenue | 1.57x | 1.67x | 1.8x | 2.33x |
EV/EBITDA | 9.81x | 8.97x | 9.01x | 11.29x |
Price to FCF (P/FCF) | -- | 10.38x | -- | -- |
EV/FCF | -- | 18.86x | -- | -- |
FCF Yield | -- | 9.64% | -0.61% | -4.9% |